ArticleIJID regions2025
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Objectives: To assess tuberculosis (TB) and associated factors among patients with presumptive TB with chronic kidney disease (CKD). Methods: A prospective cross-sectional study was conducted from January to December 2023 among 381 patients with CKD attending six hospitals found in five regions of Ethiopia. Sputum and urine specimens were collected and examined for TB using smear microscopy, culture, and Xpert MTB/RIF Ultra assay. Data were analyzed using SPSS version 27. Descriptive statistics and logistic regression models were executed. Results: More than half (206, 54.1%) were male, with a mean age of 45.08 years. A total of 94.0% (358) were pre-dialysis patients with CKD, and 90% (343) had additional comorbidity. TB was detected in 12.9% (49), with 10.5% (40) bacteriologically confirmed and 2.4% (9) clinically diagnosed TB. Previous or current cigarette smoking (adjusted odds ratio [aOR]; 2.82), decreased appetite (aOR; 5.97), night sweats (aOR; 2.21), diabetes comorbidity (aOR; 3.01), positive dipstick albuminuria (aOR; 5.55), less than 1-year follow-up in the renal unit (aOR; 9.49), body mass index <18.5 kg/m Conclusions: TB is a substantial cause of morbidity among patients with CKD in Ethiopia, necessitating programmatic intervention. Thus, active TB screening and surveillance among patients with CKD in Ethiopia is important.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.